{"hands_on_practices": [{"introduction": "Accurately quantifying antimicrobial resistance (AMR) genes from complex matrices like wastewater is a significant challenge due to inhibitors and variable nucleic acid recovery during extraction. This practice introduces the use of an internal spike-in control, a standard method to overcome this obstacle. By tracking the recovery of a known quantity of synthetic DNA, you can correct the measured concentration of your target gene, ensuring the final data reflects its true abundance in the original sample [@problem_id:5093254].", "problem": "A laboratory is quantifying an antimicrobial resistance (AMR) gene in a complex wastewater matrix using quantitative polymerase chain reaction (qPCR) with a synthetic spike-in control added prior to nucleic acid extraction to estimate extraction recovery. The wastewater sample volume is $V_{\\text{sample}} = 200\\,\\mathrm{mL}$. Before any processing, a known number of spike-in control copies $S_{\\text{in}} = 2.00 \\times 10^{7}$ is added to the raw sample. Nucleic acids are extracted and eluted into $V_{\\text{elute}} = 100\\,\\mu\\mathrm{L}$. For each qPCR reaction, $V_{\\text{rxn}} = 2.0\\,\\mu\\mathrm{L}$ of the eluate is used as template.\n\nThe laboratory has validated a standard curve that relates the quantification cycle $C_{q}$ to the number of template copies per reaction $N$ via the widely used linear model $C_{q} = \\alpha - \\beta \\log_{10}(N)$ under conditions of constant amplification efficiency. The calibrated parameters are $\\alpha = 38.0$ and $\\beta = 3.32$. Assume that matrix inhibition has been adequately controlled, that the spike-in and the AMR target experience the same extraction recovery, and that pipetting losses are negligible.\n\nThe qPCR measurements yield the following mean $C_{q}$ values on the same extract:\n- Spike-in control: $\\overline{C_{q,\\text{spike}}} = 25.00$.\n- AMR target: $\\overline{C_{q,\\text{AMR}}} = 30.00$.\n\nUsing only the information provided and first principles of qPCR quantification and mass balance, compute:\n1. The extraction recovery fraction $f_{\\text{rec}}$, defined as the ratio of total spike copies recovered in the elution to the total spike copies added to the sample.\n2. The recovery-corrected AMR gene concentration in the original wastewater, expressed in copies per milliliter.\n\nExpress the final answer as a single number equal to the recovery-corrected AMR gene concentration in copies per milliliter. Round your answer to three significant figures and report it in units of copies per milliliter (do not use a percentage sign anywhere; represent any fraction as a decimal).", "solution": "The problem statement has been validated and is deemed sound. It is scientifically grounded in the principles of quantitative polymerase chain reaction (qPCR), internally consistent, and well-posed, providing all necessary data for a unique solution.\n\nThe solution proceeds in two parts as requested: first, the calculation of the extraction recovery fraction, and second, the calculation of the recovery-corrected antimicrobial resistance (AMR) gene concentration.\n\nThe relationship between the quantification cycle ($C_q$) and the number of template copies per reaction ($N$) is given by the linear model:\n$$C_{q} = \\alpha - \\beta \\log_{10}(N)$$\nwhere the parameters are given as $\\alpha = 38.0$ and $\\beta = 3.32$. This equation can be rearranged to solve for the number of copies, $N$:\n$$\\log_{10}(N) = \\frac{\\alpha - C_q}{\\beta}$$\n$$N = 10^{\\frac{\\alpha - C_q}{\\beta}}$$\n\n**Part 1: Calculation of the Extraction Recovery Fraction ($f_{\\text{rec}}$)**\n\nThe extraction recovery fraction, $f_{\\text{rec}}$, is defined as the ratio of the total number of spike-in control copies recovered in the final eluate ($S_{\\text{out}}$) to the total number of copies initially added to the sample ($S_{\\text{in}}$).\n$$f_{\\text{rec}} = \\frac{S_{\\text{out}}}{S_{\\text{in}}}$$\nFirst, we determine the number of spike-in copies per qPCR reaction, $N_{\\text{spike}}$, using the measured mean quantification cycle, $\\overline{C_{q,\\text{spike}}} = 25.00$.\n$$N_{\\text{spike}} = 10^{\\frac{\\alpha - \\overline{C_{q,\\text{spike}}}}{\\beta}} = 10^{\\frac{38.0 - 25.00}{3.32}} = 10^{\\frac{13.00}{3.32}}$$\nThis value, $N_{\\text{spike}}$, is the number of copies present in the volume of eluate used for a single reaction, $V_{\\text{rxn}} = 2.0\\,\\mu\\mathrm{L}$. To find the total number of spike-in copies recovered in the entire eluate volume, $V_{\\text{elute}} = 100\\,\\mu\\mathrm{L}$, we scale $N_{\\text{spike}}$ by the ratio of the volumes.\n$$S_{\\text{out}} = N_{\\text{spike}} \\cdot \\frac{V_{\\text{elute}}}{V_{\\text{rxn}}}$$\nThe initial number of spike-in copies added to the sample is given as $S_{\\text{in}} = 2.00 \\times 10^7$. We can now formulate the expression for $f_{\\text{rec}}$:\n$$f_{\\text{rec}} = \\frac{S_{\\text{out}}}{S_{\\text{in}}} = \\frac{1}{S_{\\text{in}}} \\left( \\frac{V_{\\text{elute}}}{V_{\\text{rxn}}} \\right) N_{\\text{spike}} = \\frac{1}{S_{\\text{in}}} \\left( \\frac{V_{\\text{elute}}}{V_{\\text{rxn}}} \\right) 10^{\\frac{\\alpha - \\overline{C_{q,\\text{spike}}}}{\\beta}}$$\nSubstituting the given numerical values:\n$$f_{\\text{rec}} = \\frac{1}{2.00 \\times 10^7} \\left( \\frac{100\\,\\mu\\mathrm{L}}{2.0\\,\\mu\\mathrm{L}} \\right) 10^{\\frac{13.00}{3.32}} = \\frac{50}{2.00 \\times 10^7} \\cdot 10^{3.91566...}$$\n$$f_{\\text{rec}} = (2.5 \\times 10^{-6}) \\cdot (8234.2...) \\approx 0.0205855$$\nThe extraction recovery is approximately $2.06\\%$.\n\n**Part 2: Calculation of the Recovery-Corrected AMR Gene Concentration**\n\nThe final goal is to determine the concentration of the AMR gene in the original wastewater sample, $C_{\\text{AMR}}$, in units of copies per milliliter.\n\nFirst, we calculate the number of AMR gene copies per qPCR reaction, $N_{\\text{AMR}}$, using its measured mean quantification cycle, $\\overline{C_{q,\\text{AMR}}} = 30.00$.\n$$N_{\\text{AMR}} = 10^{\\frac{\\alpha - \\overline{C_{q,\\text{AMR}}}}{\\beta}} = 10^{\\frac{38.0 - 30.00}{3.32}} = 10^{\\frac{8.00}{3.32}}$$\n\nNext, we calculate the total number of AMR gene copies present in the eluate, $A_{\\text{elute}}$, by scaling $N_{\\text{AMR}}$ by the volume ratio.\n$$A_{\\text{elute}} = N_{\\text{AMR}} \\cdot \\frac{V_{\\text{elute}}}{V_{\\text{rxn}}}$$\n\nThis value, $A_{\\text{elute}}$, represents the number of copies recovered after extraction. Based on the assumption that the AMR target and the spike-in control have the same extraction recovery, we can find the original number of AMR copies in the sample, $A_{\\text{sample}}$, by dividing the recovered amount by the recovery fraction $f_{\\text{rec}}$.\n$$A_{\\text{sample}} = \\frac{A_{\\text{elute}}}{f_{\\text{rec}}}$$\n\nThe concentration, $C_{\\text{AMR}}$, is the total number of copies in the original sample, $A_{\\text{sample}}$, divided by the original sample volume, $V_{\\text{sample}} = 200\\,\\mathrm{mL}$.\n$$C_{\\text{AMR}} = \\frac{A_{\\text{sample}}}{V_{\\text{sample}}} = \\frac{1}{V_{\\text{sample}}} \\frac{A_{\\text{elute}}}{f_{\\text{rec}}}$$\n\nWe can substitute the expressions for $A_{\\text{elute}}$ and $f_{\\text{rec}}$ to obtain a comprehensive formula:\n$$C_{\\text{AMR}} = \\frac{1}{V_{\\text{sample}}} \\frac{N_{\\text{AMR}} \\cdot \\left( \\frac{V_{\\text{elute}}}{V_{\\text{rxn}}} \\right)}{\\frac{1}{S_{\\text{in}}} \\left( \\frac{V_{\\text{elute}}}{V_{\\text{rxn}}} \\right) N_{\\text{spike}}}$$\nThe dilution factor $\\frac{V_{\\text{elute}}}{V_{\\text{rxn}}}$ cancels out, simplifying the expression significantly. This cancellation is expected, as the ratio of target to spike-in copies is constant throughout the post-extraction dilutions.\n$$C_{\\text{AMR}} = \\frac{1}{V_{\\text{sample}}} \\frac{N_{\\text{AMR}} \\cdot S_{\\text{in}}}{N_{\\text{spike}}} = \\frac{S_{\\text{in}}}{V_{\\text{sample}}} \\frac{N_{\\text{AMR}}}{N_{\\text{spike}}}$$\nNow, substituting the exponential forms of $N_{\\text{AMR}}$ and $N_{\\text{spike}}$:\n$$C_{\\text{AMR}} = \\frac{S_{\\text{in}}}{V_{\\text{sample}}} \\frac{10^{(\\alpha - \\overline{C_{q,\\text{AMR}}})/\\beta}}{10^{(\\alpha - \\overline{C_{q,\\text{spike}}})/\\beta}} = \\frac{S_{\\text{in}}}{V_{\\text{sample}}} 10^{\\frac{(\\alpha - \\overline{C_{q,\\text{AMR}}}) - (\\alpha - \\overline{C_{q,\\text{spike}}})}{\\beta}}$$\nThe intercept $\\alpha$ also cancels, yielding the final, elegant relationship:\n$$C_{\\text{AMR}} = \\frac{S_{\\text{in}}}{V_{\\text{sample}}} 10^{\\frac{\\overline{C_{q,\\text{spike}}} - \\overline{C_{q,\\text{AMR}}}}{\\beta}}$$\nThis equation demonstrates that the target concentration can be determined from the spike-in concentration, the sample volume, and the difference in quantification cycles ($\\Delta C_q$) between the spike-in and the target.\n\nPlugging in the given values:\n$$C_{\\text{AMR}} = \\frac{2.00 \\times 10^7\\,\\text{copies}}{200\\,\\mathrm{mL}} \\cdot 10^{\\frac{25.00 - 30.00}{3.32}}$$\n$$C_{\\text{AMR}} = (1.00 \\times 10^5\\,\\text{copies/mL}) \\cdot 10^{\\frac{-5.00}{3.32}}$$\n$$C_{\\text{AMR}} = (1.00 \\times 10^5) \\cdot 10^{-1.506024...} \\approx (1.00 \\times 10^5) \\cdot 0.0311863$$\n$$C_{\\text{AMR}} \\approx 3118.63\\,\\text{copies/mL}$$\nRounding the result to three significant figures, we get $3120\\,\\text{copies/mL}$. In scientific notation, this is $3.12 \\times 10^3\\,\\text{copies/mL}$.", "answer": "$$\\boxed{3.12 \\times 10^3}$$", "id": "5093254"}, {"introduction": "While accurate quantification of individual samples is essential, the reliability of your findings depends on the integrity of the entire experimental run. This exercise simulates the critical quality control (QC) process used in diagnostic laboratories, where you must evaluate a suite of controls against predefined acceptance criteria. Mastering this skill is crucial for ensuring that your results are free from contamination and that the assay is performing correctly, thereby guaranteeing the validity of your conclusions [@problem_id:5093263].", "problem": "A clinical laboratory is validating a new multiplex real-time quantitative Polymerase Chain Reaction (qPCR) assay for Antimicrobial Resistance (AMR) gene detection targeting three loci: mecA, blaCTX-M, and vanA, with an Internal Amplification Control (IAC) included in every well. The run includes a No Template Control (NTC), a Negative Extraction Control (NEC), a Positive Control (PC) containing all three AMR targets at a known copy number, and a five-point $10$-fold dilution standard curve for blaCTX-M. The laboratory’s Standard Operating Procedure (SOP) defines the following predefined acceptance criteria for run control outcomes:\n\n- NTC criterion: No AMR target amplification is permitted; any exponential amplification with cycle quantification (Cq) value $\\mathrm{Cq} \\le 40$ constitutes failure for that target. The IAC in the NTC must amplify with $\\mathrm{Cq}$ between $26$ and $32$.\n- NEC criterion: No AMR target amplification is permitted; any exponential amplification with $\\mathrm{Cq} \\le 40$ constitutes failure for that target. The IAC must amplify with $\\mathrm{Cq}$ between $26$ and $32$.\n- PC criterion at $10^4$ copies per reaction: For mecA, expected $\\mathrm{Cq}$ window is $22.0 \\pm 1.0$; for blaCTX-M, $24.0 \\pm 1.0$; for vanA, $23.0 \\pm 1.0$. Duplicate wells must have $\\Delta \\mathrm{Cq} \\le 0.5$. The IAC may be delayed or suppressed in PC wells and is not required to meet the IAC range in those wells.\n- Standard curve (blaCTX-M) criterion: A $5$-point, $10$-fold dilution series must yield a slope between $-3.1$ and $-3.6$, coefficient of determination ($R^2$) $\\ge 0.99$, and $y$-intercept within $36 \\pm 2$. Duplicate wells at each dilution must have $\\Delta \\mathrm{Cq} \\le 0.5$.\n- Internal Amplification Control (IAC) in non-target wells: In wells lacking AMR target amplification (e.g., NTC, NEC, and target-negative clinical specimens), IAC $\\mathrm{Cq}$ must be between $26$ and $32$.\n- Run-level acceptance: All relevant controls for all targets must meet their acceptance criteria; any control failure for any AMR target requires rejection of the entire run.\n\nThe following control outcomes are obtained (each entry represents duplicate wells):\n\n- NTC: mecA undetermined/undetermined; blaCTX-M $\\mathrm{Cq} = 39.8/39.9$; vanA undetermined/undetermined; IAC $\\mathrm{Cq} = 28.7/28.9$.\n- NEC: mecA undetermined/undetermined; blaCTX-M undetermined/undetermined; vanA undetermined/undetermined; IAC $\\mathrm{Cq} = 29.3/29.0$.\n- PC ($10^4$ copies per reaction): mecA $\\mathrm{Cq} = 22.3/22.6$; blaCTX-M $\\mathrm{Cq} = 24.5/24.7$; vanA $\\mathrm{Cq} = 23.2/23.3$; IAC $\\mathrm{Cq} = 35.2/35.5$.\n- blaCTX-M standard curve summary ($10^5$ to $10^1$ copies per reaction, $5$ points, duplicates): slope $-3.55$, $R^2 = 0.995$, $y$-intercept $= 37.9$, maximum duplicate $\\Delta \\mathrm{Cq}$ across points $= 0.3$.\n\nFrom first principles of qPCR performance and quality control, evaluate these outcomes against the SOP acceptance criteria and choose the most appropriate run-level decision.\n\nOptions:\n\nA. Accept the run; all control criteria are satisfied.\n\nB. Reject the run due to nonconforming standard curve efficiency.\n\nC. Reject the run due to contamination indicated by blaCTX-M amplification in the No Template Control; repeat the entire run.\n\nD. Accept results for mecA and vanA, but reject only blaCTX-M results; no need to repeat the entire run.", "solution": "### Problem Validation\n\n#### Step 1: Extract Givens\n\nThe problem statement provides the following information:\n\n**Assay and Targets:**\n- A multiplex real-time quantitative Polymerase Chain Reaction (qPCR) assay.\n- Targets: `mecA`, `blaCTX-M`, `vanA`.\n- An Internal Amplification Control (IAC) is included in every well.\n\n**Controls:**\n- No Template Control (NTC)\n- Negative Extraction Control (NEC)\n- Positive Control (PC) containing all three AMR targets at $10^4$ copies per reaction.\n- A five-point, $10$-fold dilution standard curve for `blaCTX-M`.\n\n**SOP Acceptance Criteria:**\n- **NTC criterion:** No AMR target amplification permitted. Failure is defined as any exponential amplification with a cycle quantification (Cq) value $\\mathrm{Cq} \\le 40$ for any AMR target. The IAC must amplify with $\\mathrm{Cq}$ between $26$ and $32$.\n- **NEC criterion:** No AMR target amplification permitted. Failure is defined as any exponential amplification with $\\mathrm{Cq} \\le 40$ for any AMR target. The IAC must amplify with $\\mathrm{Cq}$ between $26$ and $32$.\n- **PC criterion (at $10^4$ copies/reaction):**\n    - `mecA`: expected $\\mathrm{Cq}$ window is $22.0 \\pm 1.0$ (i.e., $[21.0, 23.0]$).\n    - `blaCTX-M`: expected $\\mathrm{Cq}$ window is $24.0 \\pm 1.0$ (i.e., $[23.0, 25.0]$).\n    - `vanA`: expected $\\mathrm{Cq}$ window is $23.0 \\pm 1.0$ (i.e., $[22.0, 24.0]$).\n    - Duplicate wells must have $\\Delta \\mathrm{Cq} \\le 0.5$.\n    - IAC may be delayed or suppressed.\n- **Standard curve (`blaCTX-M`) criterion:**\n    - Slope between $-3.1$ and $-3.6$.\n    - Coefficient of determination ($R^2$) $\\ge 0.99$.\n    - $y$-intercept within $36 \\pm 2$ (i.e., $[34, 38]$).\n    - Duplicate wells at each dilution must have $\\Delta \\mathrm{Cq} \\le 0.5$.\n- **IAC in non-target wells criterion:** In wells without AMR target amplification, IAC $\\mathrm{Cq}$ must be between $26$ and $32$.\n- **Run-level acceptance criterion:** All relevant controls for all targets must meet their criteria. Any control failure for any AMR target requires rejection of the entire run.\n\n**Obtained Control Outcomes:**\n- **NTC (duplicates):**\n    - `mecA`: undetermined/undetermined\n    - `blaCTX-M`: $\\mathrm{Cq} = 39.8/39.9$\n    - `vanA`: undetermined/undetermined\n    - IAC: $\\mathrm{Cq} = 28.7/28.9$\n- **NEC (duplicates):**\n    - `mecA`: undetermined/undetermined\n    - `blaCTX-M`: undetermined/undetermined\n    - `vanA`: undetermined/undetermined\n    - IAC: $\\mathrm{Cq} = 29.3/29.0$\n- **PC ($10^4$ copies/reaction, duplicates):**\n    - `mecA`: $\\mathrm{Cq} = 22.3/22.6$\n    - `blaCTX-M`: $\\mathrm{Cq} = 24.5/24.7$\n    - `vanA`: $\\mathrm{Cq} = 23.2/23.3$\n    - IAC: $\\mathrm{Cq} = 35.2/35.5$\n- **`blaCTX-M` standard curve summary:**\n    - Slope: $-3.55$\n    - $R^2$: $0.995$\n    - $y$-intercept: $37.9$\n    - Maximum duplicate $\\Delta \\mathrm{Cq}$: $0.3$\n\n#### Step 2: Validate Using Extracted Givens\n\nThe problem is scientifically grounded, well-posed, and objective. It describes a standard quality control scenario for a molecular diagnostic assay, a routine and critical process in clinical laboratories.\n- **Scientifically Grounded:** The principles of qPCR, including the use of Cq values, standard curves, controls (NTC, NEC, PC, IAC), and acceptance criteria (slope, $R^2$, Cq ranges) are fundamental to the field of molecular diagnostics. The target genes (`mecA`, `blaCTX-M`, `vanA`) are well-established and clinically significant antimicrobial resistance markers.\n- **Well-Posed:** The problem provides a clear set of SOP criteria and a complete set of experimental results. The question asks for a definitive decision (accept/reject) based on a direct comparison of the results to the criteria. A unique, logical conclusion can be derived.\n- **Objective:** The language is neutral and devoid of subjective or opinion-based statements. The acceptance criteria are defined with precise numerical values, and the results are given as quantitative data.\n\nThe problem setup is complete, coherent, and internally consistent. It does not violate any scientific principles, is not ambiguous, and presents a realistic scenario.\n\n#### Step 3: Verdict and Action\n\nThe problem statement is **valid**. The solution will proceed by systematically evaluating the provided control outcomes against the SOP criteria.\n\n### Solution Derivation\n\nThe run-level decision must be made by comparing each control's outcome to the predefined SOP criteria.\n\n**1. No Template Control (NTC) Evaluation:**\n- **SOP Criterion:** No AMR target amplification with $\\mathrm{Cq} \\le 40$. IAC $\\mathrm{Cq}$ must be between $26$ and $32$.\n- **Observed Outcome:**\n    - `mecA` and `vanA` are \"undetermined,\" which means no amplification was detected. This passes the criterion.\n    - `blaCTX-M` shows amplification with $\\mathrm{Cq}$ values of $39.8$ and $39.9$. The criterion for failure is \"any exponential amplification with cycle quantification (Cq) value $\\mathrm{Cq} \\le 40$\". Since both $39.8 \\le 40$ and $39.9 \\le 40$, this constitutes a **failure** for the `blaCTX-M` target. This result indicates probable low-level contamination.\n    - IAC $\\mathrm{Cq}$ values are $28.7$ and $28.9$. Both are within the required range of $[26, 32]$. The IAC part passes.\n- **NTC Verdict:** **FAIL**. The amplification of `blaCTX-M` violates the NTC acceptance criterion.\n\n**2. Negative Extraction Control (NEC) Evaluation:**\n- **SOP Criterion:** No AMR target amplification with $\\mathrm{Cq} \\le 40$. IAC $\\mathrm{Cq}$ must be between $26$ and $32$.\n- **Observed Outcome:** All AMR targets are \"undetermined.\" The IAC $\\mathrm{Cq}$ values are $29.3$ and $29.0$. Both are within the required range of $[26, 32]$.\n- **NEC Verdict:** **PASS**. All criteria are met. This suggests the contamination seen in the NTC is not from the extraction reagents.\n\n**3. Positive Control (PC) Evaluation:**\n- **SOP Criterion:** `mecA` $\\mathrm{Cq} \\in [21.0, 23.0]$, `blaCTX-M` $\\mathrm{Cq} \\in [23.0, 25.0]$, `vanA` $\\mathrm{Cq} \\in [22.0, 24.0]$. For all targets, duplicate $\\Delta \\mathrm{Cq} \\le 0.5$. IAC amplification is not evaluated.\n- **Observed Outcome:**\n    - `mecA`: $\\mathrm{Cq}$s are $22.3$ and $22.6$. Both are within $[21.0, 23.0]$. $\\Delta \\mathrm{Cq} = |22.6 - 22.3| = 0.3$, which is $\\le 0.5$. This passes.\n    - `blaCTX-M`: $\\mathrm{Cq}$s are $24.5$ and $24.7$. Both are within $[23.0, 25.0]$. $\\Delta \\mathrm{Cq} = |24.7 - 24.5| = 0.2$, which is $\\le 0.5$. This passes.\n    - `vanA`: $\\mathrm{Cq}$s are $23.2$ and $23.3$. Both are within $[22.0, 24.0]$. $\\Delta \\mathrm{Cq} = |23.3 - 23.2| = 0.1$, which is $\\le 0.5$. This passes.\n- **PC Verdict:** **PASS**. All criteria are met.\n\n**4. `blaCTX-M` Standard Curve Evaluation:**\n- **SOP Criterion:** Slope $\\in [-3.6, -3.1]$, $R^2 \\ge 0.99$, $y$-intercept $\\in [34, 38]$, and maximum duplicate $\\Delta \\mathrm{Cq} \\le 0.5$.\n- **Observed Outcome:**\n    - Slope = $-3.55$. This is within the accepted range.\n    - $R^2 = 0.995$. This is $\\ge 0.99$.\n    - $y$-intercept = $37.9$. This is within the accepted range of $[34, 38]$.\n    - Maximum duplicate $\\Delta \\mathrm{Cq} = 0.3$. This is $\\le 0.5$.\n- **Standard Curve Verdict:** **PASS**. All criteria are met.\n\n**5. Run-Level Decision:**\n- **SOP Criterion:** \"All relevant controls for all targets must meet their acceptance criteria; any control failure for any AMR target requires rejection of the entire run.\"\n- **Conclusion:** The NTC failed due to amplification of the `blaCTX-M` target. According to the explicitly stated run-level acceptance rule, this single failure mandates the rejection of the entire run.\n\n### Option-by-Option Analysis\n\n**A. Accept the run; all control criteria are satisfied.**\n**Incorrect.** This is false. The No Template Control (NTC) failed for the `blaCTX-M` target, as it showed amplification with $\\mathrm{Cq}$ values ($\\mathrm{Cq}=39.8/39.9$) that are less than or equal to the failure cutoff of $\\mathrm{Cq}=40$.\n\n**B. Reject the run due to nonconforming standard curve efficiency.**\n**Incorrect.** The standard curve parameters are all within the SOP--defined acceptable ranges. The slope of $-3.55$ is between $-3.1$ and $-3.6$. The $R^2$ of $0.995$ is $\\ge 0.99$. The $y$-intercept of $37.9$ is within $36 \\pm 2$. The amplification efficiency, calculated as $E = 10^{-1/\\text{slope}} - 1 = 10^{-1/(-3.55)} - 1 \\approx 0.913$ or $91.3\\%$, falls within the high-quality range generally accepted for qPCR (typically $90\\%-110\\%$), which is consistent with the accepted slope range. Therefore, the standard curve is conforming, not nonconforming.\n\n**C. Reject the run due to contamination indicated by blaCTX-M amplification in the No Template Control; repeat the entire run.**\n**Correct.** This option accurately identifies the specific failure: the late but definite amplification of `blaCTX-M` in the NTC. Per the SOP, any amplification with $\\mathrm{Cq} \\le 40$ in a negative control is a failure. This failure is interpreted as evidence of contamination. The run-level acceptance criterion is strict: \"any control failure ... requires rejection of the entire run.\" Therefore, rejecting the entire run is the correct course of action.\n\n**D. Accept results for mecA and vanA, but reject only blaCTX-M results; no need to repeat the entire run.**\n**Incorrect.** This action contradicts the explicit run-level acceptance criterion in the SOP, which states that \"any control failure for any AMR target requires rejection of the entire run.\" In a clinical diagnostic setting, a contamination event for one target casts doubt on the integrity of the entire plate setup and all results obtained from it. It is not permissible to selectively accept results from a failed run.", "answer": "$$\\boxed{C}$$", "id": "5093263"}, {"introduction": "After generating accurate and quality-controlled data, the final step is to translate those numbers into biological insight. This practice explores the relationship between the expression level of an efflux pump gene and the phenotypic level of resistance, quantified by the Minimum Inhibitory Concentration (MIC). By applying a linear regression model to log-transformed data, you will learn to statistically test the hypothesis that increased gene expression directly contributes to higher levels of antibiotic resistance, a fundamental question in AMR research [@problem_id:5093259].", "problem": "You are given paired measurements linking gene expression to antimicrobial susceptibility for multiple bacterial isolates. Under the Central Dogma of Molecular Biology, transcriptional upregulation of efflux pump genes increases the concentration of efflux pump proteins, which can export antibiotic molecules from the cell. This export reduces intracellular antibiotic concentration, plausibly increasing the Minimum Inhibitory Concentration (MIC) required to inhibit bacterial growth. In molecular and immunodiagnostics, gene expression fold-change is commonly quantified using Real-Time Quantitative Polymerase Chain Reaction (RT-qPCR), often summarized as relative fold-change values, and phenotypic resistance is quantified by MIC in microgram per milliliter ($\\mu \\mathrm{g}/\\mathrm{mL}$).\n\nAssume a statistical model where the log-transformed MIC depends linearly on the log-transformed expression fold-change with additive, independent, identically distributed Gaussian noise. Specifically, let $x_i = \\log_2(\\mathrm{FC}_i)$ and $y_i = \\log_2(\\mathrm{MIC}_i)$ for isolate index $i$, and assume\n$$\ny_i = \\beta_0 + \\beta_1 x_i + \\varepsilon_i,\n$$\nwhere $\\varepsilon_i$ are independent, identically distributed with $\\varepsilon_i \\sim \\mathcal{N}(0,\\sigma^2)$, and $\\beta_0$, $\\beta_1$, and $\\sigma^2$ are unknown parameters. Using these assumptions as the fundamental base, fit the model by ordinary least squares and test whether increased expression is associated with increased MIC by evaluating the two-sided statistical significance of the slope $\\beta_1$ at significance level $\\alpha = 0.05$ (express $\\alpha$ as a decimal). Report whether the association is significantly positive when the estimated slope is greater than $0$ and the two-sided $p$-value is less than $\\alpha$.\n\nImplement the following for each provided dataset:\n- Compute the estimated slope $\\hat{\\beta}_1$ (a float), the estimated intercept $\\hat{\\beta}_0$ (a float), the two-sided $p$-value $p$ for testing $H_0: \\beta_1 = 0$ versus $H_1: \\beta_1 \\neq 0$ (a float), the coefficient of determination $R^2$ (a float), and the boolean decision $S$ indicating a significantly positive association defined by $(\\hat{\\beta}_1 > 0) \\wedge (p < \\alpha)$.\n- All MIC values are provided in $\\mu \\mathrm{g}/\\mathrm{mL}$; there is no unit conversion in the output because the outputs are dimensionless floats and a boolean.\n- Angles do not appear in this problem; no angle units are required.\n- Percentages do not appear; where a threshold is used (such as $\\alpha$), it must be represented as a decimal.\n\nTest suite (each dataset is a pair of lists: expression fold-change values and MIC values):\n- Dataset $A$ (general positive association):\n  - $\\mathrm{FC}$: {$0.90, 1.00, 1.20, 1.50, 2.00, 2.50, 3.00, 4.00$}\n  - $\\mathrm{MIC}$ in $\\mu \\mathrm{g}/\\mathrm{mL}$: {$0.25, 0.25, 0.40, 0.50, 1.00, 1.20, 1.50, 2.00$}\n- Dataset $B$ (approximately no association):\n  - $\\mathrm{FC}$: {$0.80, 1.00, 1.20, 1.40, 1.60, 1.80, 2.00, 2.20$}\n  - $\\mathrm{MIC}$ in $\\mu \\mathrm{g}/\\mathrm{mL}$: {$0.50, 0.52, 0.48, 0.49, 0.51, 0.50, 0.49, 0.50$}\n- Dataset $C$ (inverse association):\n  - $\\mathrm{FC}$: {$1.00, 1.50, 2.00, 2.50, 3.00, 3.50$}\n  - $\\mathrm{MIC}$ in $\\mu \\mathrm{g}/\\mathrm{mL}$: {$2.00, 1.80, 1.60, 1.30, 1.10, 0.90$}\n- Dataset $D$ (small sample size boundary case):\n  - $\\mathrm{FC}$: {$1.00, 2.00, 4.00$}\n  - $\\mathrm{MIC}$ in $\\mu \\mathrm{g}/\\mathrm{mL}$: {$1.00, 1.20, 2.20$}\n\nRequired final output format:\n- Your program should produce a single line of output containing the results as a comma-separated list enclosed in square brackets, where each dataset’s result is itself a list in the order $[\\,\\hat{\\beta}_1,\\hat{\\beta}_0,p,R^2,S\\,]$. For example, the top-level output should look like $[\\,\\text{result}_A,\\text{result}_B,\\text{result}_C,\\text{result}_D\\,]$, where each $\\text{result}_\\cdot$ is a list containing the specified values in that order.", "solution": "The problem requires the analysis of paired gene expression and antimicrobial susceptibility data using a simple linear regression model. The objective is to determine if an increase in gene expression fold-change ($\\mathrm{FC}$) is statistically associated with an increase in the Minimum Inhibitory Concentration ($\\mathrm{MIC}$). The analysis will be conducted on log-transformed data as specified.\n\nThe statistical model is given by:\n$$\ny_i = \\beta_0 + \\beta_1 x_i + \\varepsilon_i\n$$\nwhere $x_i = \\log_2(\\mathrm{FC}_i)$ is the log-transformed gene expression fold-change and $y_i = \\log_2(\\mathrm{MIC}_i)$ is the log-transformed MIC for the $i$-th bacterial isolate. The terms $\\varepsilon_i$ represent independent, identically distributed random errors from a Gaussian distribution with mean $0$ and variance $\\sigma^2$, i.e., $\\varepsilon_i \\sim \\mathcal{N}(0, \\sigma^2)$.\n\nThe task is to compute estimates for the model parameters ($\\beta_0, \\beta_1$), evaluate the statistical significance of the slope $\\beta_1$, and assess the model's goodness-of-fit. This involves the following steps for each dataset.\n\nFirst, the raw data, consisting of $\\mathrm{FC}$ and $\\mathrm{MIC}$ values, must be transformed. Let the given data be a set of $n$ pairs $(\\mathrm{FC}_i, \\mathrm{MIC}_i)$. We compute the variables for our linear model as $x_i = \\log_2(\\mathrm{FC}_i)$ and $y_i = \\log_2(\\mathrm{MIC}_i)$ for $i = 1, \\dots, n$.\n\nNext, we use the method of ordinary least squares (OLS) to find the estimates $\\hat{\\beta}_1$ and $\\hat{\\beta}_0$ that minimize the sum of squared residuals. The formulas for these estimates are derived from this minimization principle. Let $\\bar{x} = \\frac{1}{n}\\sum_{i=1}^n x_i$ and $\\bar{y} = \\frac{1}{n}\\sum_{i=1}^n y_i$ be the sample means of the transformed data.\n\nThe estimated slope, $\\hat{\\beta}_1$, is calculated as:\n$$\n\\hat{\\beta}_1 = \\frac{\\sum_{i=1}^n (x_i - \\bar{x})(y_i - \\bar{y})}{\\sum_{i=1}^n (x_i - \\bar{x})^2} = \\frac{S_{xy}}{S_{xx}}\n$$\n\nThe estimated intercept, $\\hat{\\beta}_0$, is then calculated using the means and the estimated slope:\n$$\n\\hat{\\beta}_0 = \\bar{y} - \\hat{\\beta}_1 \\bar{x}\n$$\n\nTo test the hypothesis of no association ($H_0: \\beta_1 = 0$) against the alternative of some association ($H_1: \\beta_1 \\neq 0$), we compute a $t$-statistic. This requires an estimate of the standard error of the slope, $\\widehat{SE}(\\hat{\\beta}_1)$. First, we calculate the sum of squared errors (or residuals), $SSE$:\n$$\nSSE = \\sum_{i=1}^n (y_i - \\hat{y}_i)^2 = \\sum_{i=1}^n (y_i - (\\hat{\\beta}_0 + \\hat{\\beta}_1 x_i))^2\n$$\nThe unbiased estimator for the error variance $\\sigma^2$ is $\\hat{\\sigma}^2 = \\frac{SSE}{n-2}$, where $n-2$ are the degrees of freedom ($df$).\n\nThe standard error of the slope estimate is then:\n$$\n\\widehat{SE}(\\hat{\\beta}_1) = \\sqrt{\\frac{\\hat{\\sigma}^2}{\\sum_{i=1}^n (x_i - \\bar{x})^2}} = \\sqrt{\\frac{\\hat{\\sigma}^2}{S_{xx}}}\n$$\n\nThe $t$-statistic for the slope coefficient is:\n$$\nt = \\frac{\\hat{\\beta}_1 - 0}{\\widehat{SE}(\\hat{\\beta}_1)} = \\frac{\\hat{\\beta}_1}{\\widehat{SE}(\\hat{\\beta}_1)}\n$$\nUnder the null hypothesis, this statistic follows a Student's $t$-distribution with $df = n-2$ degrees of freedom. The two-sided $p$-value is the probability of observing a test statistic at least as extreme as the one computed, assuming $H_0$ is true:\n$$\np = 2 \\cdot P(T_{n-2} \\ge |t|)\n$$\nwhere $T_{n-2}$ is a random variable following the $t$-distribution with $n-2$ degrees of freedom.\n\nThe coefficient of determination, $R^2$, measures the proportion of the variance in the dependent variable $y$ that is predictable from the independent variable $x$. It is calculated as:\n$$\nR^2 = 1 - \\frac{SSE}{SST}\n$$\nwhere $SST = \\sum_{i=1}^n (y_i - \\bar{y})^2$ is the total sum of squares. An equivalent formula is $R^2 = \\frac{S_{xy}^2}{S_{xx}S_{yy}}$, where $S_{yy} = SST$.\n\nFinally, we determine if there is a significantly positive association. The boolean decision variable $S$ is defined by the rule: the association is significantly positive if the estimated slope $\\hat{\\beta}_1$ is positive and the $p$-value is less than the specified significance level $\\alpha = 0.05$.\n$$\nS = (\\hat{\\beta}_1 > 0) \\land (p < 0.05)\n$$\n\nThis complete procedure will be implemented and applied to each of the four provided datasets to generate the required output list $[\\hat{\\beta}_1, \\hat{\\beta}_0, p, R^2, S]$ for each.", "answer": "```python\n# The complete and runnable Python 3 code goes here.\n# Imports must adhere to the specified execution environment.\nimport numpy as np\nfrom scipy import stats\n\ndef solve():\n    \"\"\"\n    Solves the problem by performing linear regression analysis on provided datasets.\n    \"\"\"\n\n    # Define the significance level alpha\n    alpha = 0.05\n\n    # Define the test cases from the problem statement.\n    test_cases = [\n        # Dataset A\n        (\n            [0.90, 1.00, 1.20, 1.50, 2.00, 2.50, 3.00, 4.00],\n            [0.25, 0.25, 0.40, 0.50, 1.00, 1.20, 1.50, 2.00]\n        ),\n        # Dataset B\n        (\n            [0.80, 1.00, 1.20, 1.40, 1.60, 1.80, 2.00, 2.20],\n            [0.50, 0.52, 0.48, 0.49, 0.51, 0.50, 0.49, 0.50]\n        ),\n        # Dataset C\n        (\n            [1.00, 1.50, 2.00, 2.50, 3.00, 3.50],\n            [2.00, 1.80, 1.60, 1.30, 1.10, 0.90]\n        ),\n        # Dataset D\n        (\n            [1.00, 2.00, 4.00],\n            [1.00, 1.20, 2.20]\n        )\n    ]\n\n    results = []\n    \n    for fc_values, mic_values in test_cases:\n        # Perform regression analysis for each dataset\n        result = _calculate_regression_stats(fc_values, mic_values, alpha)\n        results.append(list(result))\n\n    # Final print statement in the exact required format.\n    # The map(str, ...) converts each list in results to its string representation.\n    print(f\"[{','.join(map(str, results))}]\")\n\ndef _calculate_regression_stats(fc, mic, alpha):\n    \"\"\"\n    Calculates regression statistics for a single dataset.\n\n    Args:\n        fc (list): A list of fold-change values.\n        mic (list): A list of MIC values.\n        alpha (float): The significance level.\n\n    Returns:\n        tuple: A tuple containing (beta1_hat, beta0_hat, p_value, r_squared, S).\n    \"\"\"\n    # 1. Transform data to log base 2\n    x = np.log2(np.array(fc))\n    y = np.log2(np.array(mic))\n    \n    n = len(x)\n    \n    # 2. Calculate means\n    x_mean = np.mean(x)\n    y_mean = np.mean(y)\n    \n    # 3. Calculate sum of squares S_xx, S_yy, and S_xy\n    s_xx = np.sum((x - x_mean)**2)\n    s_yy = np.sum((y - y_mean)**2)\n    s_xy = np.sum((x - x_mean) * (y - y_mean))\n    \n    # 4. Calculate OLS estimates for beta1 and beta0\n    # Check for s_xx == 0 to avoid division by zero, though not expected for given data\n    if s_xx == 0:\n        # This case is undefined for linear regression slope\n        return (float('nan'), float('nan'), float('nan'), float('nan'), False)\n        \n    beta1_hat = s_xy / s_xx\n    beta0_hat = y_mean - beta1_hat * x_mean\n    \n    # 5. Calculate the coefficient of determination (R^2)\n    # Check for s_yy == 0 to avoid division by zero\n    if s_yy == 0:\n        r_squared = 1.0 if s_xy == 0 else float('nan')\n    else:\n        r_squared = s_xy**2 / (s_xx * s_yy)\n\n    # 6. Calculate the p-value for the slope (beta1)\n    # Degrees of freedom for t-test\n    df = n - 2\n    \n    if df <= 0:\n        # p-value is not well-defined\n        p_value = float('nan')\n    else:\n        # Sum of squared errors (residuals)\n        sse = s_yy - beta1_hat * s_xy\n        # Estimate of the error variance\n        sigma2_hat = sse / df\n        # Standard error of the slope estimate\n        se_beta1_hat = np.sqrt(sigma2_hat / s_xx)\n        \n        # t-statistic\n        if se_beta1_hat == 0:\n             # perfect fit, p-value should reflect this (depends on beta1_hat)\n             t_stat = float('inf') if beta1_hat != 0 else 0\n        else:\n             t_stat = beta1_hat / se_beta1_hat\n\n        # Two-sided p-value from t-distribution\n        p_value = 2 * stats.t.sf(np.abs(t_stat), df)\n\n    # 7. Determine if the association is significantly positive\n    S = (beta1_hat > 0) and (p_value < alpha)\n    \n    return (beta1_hat, beta0_hat, p_value, r_squared, S)\n\nsolve()\n```", "id": "5093259"}]}